Unlike existing treatments that focus on rehabilitation or reducing the risk of an additional stroke, the experimental drug targets the “stickiness” that can prevent injured brain tissue from functioning as it should.
Unlike existing treatments that focus on rehabilitation or reducing the risk of an additional stroke, the experimental drug targets the “stickiness” that can prevent injured brain tissue from functioning as it should.
Comments are closed.